CytomX Therapeutics Inc (CTMX) Insider Trading
- $7,816,720.00
- $50,438,599.91
- Aug. 20, 2024
- Sean A Mccarthy
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 20, 2024 | CEO | 13,898 | $1.23 | Sell | $17,094.54 | |
Aug. 20, 2024 | CFO | 1,984 | $1.23 | Sell | $2,440.32 | |
Aug. 20, 2024 | Insider | 4,181 | $1.23 | Sell | $5,142.63 | |
March 19, 2024 | Insider | 6,562 | $2.09 | Sell | $13,714.58 | |
March 19, 2024 | CEO | 20,223 | $2.09 | Sell | $42,266.07 | |
March 19, 2024 | SVP | 2,971 | $2.09 | Sell | $6,209.39 | |
March 19, 2024 | General Counsel | 5,268 | $2.09 | Sell | $11,010.12 | |
Dec. 20, 2023 | SVP | 4,077 | $1.38 | Sell | $5,626.26 | |
Dec. 20, 2023 | CEO | 13,551 | $1.38 | Sell | $18,700.38 | |
Sept. 22, 2023 | General Counsel | 5,486 | $1.30 | Sell | $7,131.80 | |
Sept. 22, 2023 | CEO | 14,601 | $1.30 | Sell | $18,981.30 | |
Sept. 22, 2023 | SVP | 4,119 | $1.30 | Sell | $5,354.70 | |
March 29, 2023 | Director | 5,000 | $1.55 | Buy | $7,750.00 | |
March 16, 2023 | EVP | 4,257 | $1.98 | Sell | $8,428.86 | |
March 16, 2023 | General Counsel | 2,037 | $1.98 | Sell | $4,033.26 | |
March 16, 2023 | SVP | 516 | $1.98 | Sell | $1,021.68 | |
March 16, 2023 | CEO | 7,121 | $1.88 | Sell | $13,387.48 | |
March 16, 2023 | CFO | 1,748 | $1.98 | Sell | $3,461.04 | |
July 20, 2022 | General Counsel | 5,602 | $1.42 | Sell | $7,954.84 | |
July 20, 2022 | Insider | 4,206 | $1.42 | Sell | $5,972.52 | |
July 20, 2022 | CFO | 3,949 | $1.42 | Sell | $5,607.58 | |
July 20, 2022 | EVP | 7,463 | $1.42 | Sell | $10,597.46 | |
July 20, 2022 | CEO | 14,911 | $1.42 | Sell | $21,173.62 | |
June 16, 2021 | CEO | 100,000 | $7.04 | Sell | $704,000.00 | |
March 31, 2021 | CEO | 100,000 | $7.49 | Sell | $749,000.00 | |
May 12, 2020 | CEO | 36,000 | $15.00 | Sell | $540,000.00 | |
March 4, 2019 | General Counsel | 9,000 | $10.33 | Buy | $92,970.00 | |
Dec. 12, 2018 | CFO | 3,000 | $15.00 | Sell | $45,000.00 | |
Nov. 2, 2018 | Insider | 6,526 | $15.00 | Sell | $97,890.00 | |
Nov. 1, 2018 | CFO | 3,000 | $15.00 | Sell | $45,000.00 | |
Oct. 1, 2018 | CFO | 3,000 | $18.46 | Sell | $55,380.00 | |
Sept. 4, 2018 | Insider | 13,052 | $21.86 | Sell | $285,316.72 | |
Sept. 4, 2018 | CFO | 3,000 | $22.39 | Sell | $67,170.00 | |
Aug. 1, 2018 | CFO | 3,000 | $26.05 | Sell | $78,150.00 | |
July 5, 2018 | Insider | 4,497 | $25.06 | Sell | $112,694.82 | |
July 3, 2018 | CEO | 2,028 | $25.09 | Sell | $50,882.52 | |
July 2, 2018 | Insider | 13,052 | $23.42 | Sell | $305,677.84 | |
July 2, 2018 | CFO | 3,000 | $22.56 | Sell | $67,680.00 | |
June 1, 2018 | CFO | 3,000 | $25.93 | Sell | $77,790.00 | |
May 1, 2018 | CFO | 3,000 | $26.52 | Sell | $79,560.00 | |
May 1, 2018 | CEO | 19,578 | $26.55 | Sell | $519,795.90 | |
April 2, 2018 | CFO | 3,000 | $28.12 | Sell | $84,360.00 | |
March 26, 2018 | Director | 5,000 | $31.93 | Sell | $159,650.00 | |
March 2, 2018 | CFO | 33,000 | $29.99 | Sell | $989,670.00 | |
March 2, 2018 | Insider | 16,160 | $30.00 | Sell | $484,800.00 | |
March 2, 2018 | Director | 16,181 | $30.00 | Sell | $485,430.00 | |
Feb. 28, 2018 | Insider | 23,840 | $30.00 | Sell | $715,200.00 | |
Feb. 28, 2018 | Director | 3,819 | $30.00 | Sell | $114,570.00 | |
Feb. 1, 2018 | CFO | 2,548 | $26.69 | Sell | $68,006.12 | |
Jan. 5, 2018 | Insider | 6,526 | $25.01 | Sell | $163,215.26 |
Insiders are both buying and selling CytomX Therapeutics Inc stock.
The insider traders at CytomX Therapeutics Inc are: Sean A Mccarthy, Debanjan Ray, Ix L.P. Canaan, Frederick W Gluck, Lloyd A Rowland, Robert I Tepper, Timothy M Shannon, Christopher Ogden, Jeffrey B Landau, Marcia Belvin, Amy C Peterson, Carlos Campoy, Rachel Humphrey, William Michael Kavanaugh, Cynthia J Ladd, Elaine V Jones, James E Flynn, Kevin P Starr, Robert C Goeltz II, Rock Ventures Lp Third, and Sean A. Mccarthy
The most active insider trader at CytomX Therapeutics Inc is Sean A Mccarthy with 30 trades.
Rock Ventures Lp Third has sold the most CytomX Therapeutics Inc stock with a total value of $57,387,000.00.
James E Flynn has bought the most CytomX Therapeutics Inc stock with a total value of $15,000,000.00.
The most recent insider trade for CytomX Therapeutics Inc was on Aug. 20, 2024.
The single biggest insider buy for CytomX Therapeutics Inc was from James E Flynn with a total value of $7,500,000.00 on Oct. 14, 2015.
The single biggest insider sell for CytomX Therapeutics Inc was from Rock Ventures Lp Third with a total value of $28,693,500.00 on March 27, 2017.